MedPath

A Comparison of LMA-Supreme and I-gel for the Incidence of Postoperative Sore Throat

Not Applicable
Terminated
Conditions
General Anesthesia
Registration Number
NCT02745964
Lead Sponsor
Yonsei University
Brief Summary

The purpose of this study is to investigate and compare the incidence of the postoperative sore throat between LMA supreme and I-gel.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • adult patients aged over 19 years who are scheduled for elective surgery under general anesthesia using the laryngeal mask airway
Exclusion Criteria
  • Anticipated difficult airway
  • Expected duration of surgery more than 4 hours
  • body mass index more than 35 kg/m2
  • pregnancy
  • Upper gastrointestinal surgery or open abdominal surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Postoperative sore throatwithin 24 hours after the end of surgery.

The postoperative sore throat will be evaluated after the end of surgery by the investigator who are blinded to the group assignments. The investigator will ask the participant about his/her sore throat status.

Secondary Outcome Measures
NameTimeMethod
Postoperative dysphagiawithin 24 hours after the end of surgery

The postoperative dysphagia will be evaluated after the end of surgery by the investigator who are blinded to the group assignments. The investigator will ask the participant about his/her status.

Postoperative dysphoniawithin 24 hours after the end of surgery

The postoperative dysphonia will be evaluated after the end of surgery by the investigator who are blinded to the group assignments. The investigator will ask the participant about his/her status.

Trial Locations

Locations (1)

Department of Anesthesiology and Pain MedicineSeverance Hospital, Yonsei University Health System

🇰🇷

Seoul, Korea, Korea, Republic of

Department of Anesthesiology and Pain MedicineSeverance Hospital, Yonsei University Health System
🇰🇷Seoul, Korea, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.